Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease

Collaboration Brings Unique Expertise Together Focus is to Translate IBD Gene and Biology Findings Into Potential New Treatment Options for Patients THOUSAND OAKS, Calif., Jan. 15, 2014 /PRNewswire/ — Massachusetts General Hospital (MGH), theBroad Institute, and Amgen (NASDAQ:AMGN) announced today that they have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory […]